Showing results (51-60 of 459) with videos related to
Sort By:
Pageof 46
Biological Psychiatry|August 15, 1996
Acute and long-term effectiveness of clozapine in treatment-resistant psychotic depressionR Ranjan, H Y MeltzerThe Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbensJ Ichikawa, H Y MeltzerBiological Psychiatry|September 1, 1995
Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal menH Y Meltzer, M MaesLife Sciences|January 1, 1989
Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortexS Matsubara, H Y MeltzerConvulsive Therapy|January 1, 1993
The Effect of Short-Term Electroconvulsive Treatment Plus Neuroleptics in Treatment-Resistant Schizophrenia and Schizoaffective DisorderM. Sajatovic, H. Y. MeltzerBrain Research|March 10, 2000
The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbensJ Ichikawa, H Y MeltzerThe Journal of Pharmacology and Experimental Therapeutics|November 24, 1999
R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatumJ Ichikawa, H Y MeltzerBrain Research|March 6, 1992
The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivoJ Ichikawa, H Y MeltzerThe Journal of Clinical Psychiatry|December 1, 1982
Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and manH Y Meltzer, R FlemingThe American Journal of Psychiatry|February 1, 1995
Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessmentH Y Meltzer, G OkayliPageof 46